Group 107 Ltd (TLV:G107)

Marinus Pharmaceuticals Income Statement

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	33.81	30.36	29.21	16.18	7.11
Revenue Growth (YoY)	11.35%	3.95%	80.49%	127.48%	223.02%
Cost of Revenue	24.96	23.92	24.01	11.73	4.6
Gross Profit	8.84	6.44	5.2	4.45	2.51
Selling, General & Admin	9.06	8.47	9.72	8.35	1.65
Research & Development	0.43	1.16	2.83	7.35	2.52
Other Operating Expenses	-0.02	0.11	-0.01	-	-
Operating Expenses	9.48	9.74	12.54	15.69	4.16
Operating Income	-0.64	-3.29	-7.34	-11.24	-1.65
Interest Expense	-0.2	-0.49	-0.33	-0.23	-0.15
Interest & Investment Income	0.01	0	0	0	-
Currency Exchange Gain (Loss)	-0.18	-0.09	-0.45	-0.08	-0.04
Other Non Operating Income (Expenses)	-0.07	-	-	-0.13	-
EBT Excluding Unusual Items	-1.08	-3.87	-8.12	-11.68	-1.83
Gain (Loss) on Sale of Investments	-0.04	-	-	-	-
Pretax Income	-1.12	-3.87	-8.12	-11.68	-1.83
Income Tax Expense	0.1	0.01	0.01	0.02	0
Earnings From Continuing Operations	-1.21	-3.88	-8.12	-11.7	-1.84
Minority Interest in Earnings	-0.12	-	-	1.48	1.03
Net Income	-1.34	-3.88	-8.12	-10.22	-0.8
Net Income to Common	-1.34	-3.88	-8.12	-10.22	-0.8
Shares Outstanding (Basic)	22	18	17	6	16
Shares Outstanding (Diluted)	22	18	17	6	16
Shares Change (YoY)	25.97%	4.11%	202.97%	-65.88%	-
EPS (Basic)	-0.06	-0.22	-0.48	-1.84	-0.05
EPS (Diluted)	-0.06	-0.22	-0.48	-1.84	-0.05
Free Cash Flow	-0.53	-1.74	-7.73	-9.17	-0.61
Free Cash Flow Per Share	-0.02	-0.10	-0.46	-1.65	-0.04
Gross Margin	26.16%	21.23%	17.80%	27.53%	35.34%
Operating Margin	-1.88%	-10.85%	-25.13%	-69.45%	-23.17%
Profit Margin	-3.95%	-12.77%	-27.80%	-63.17%	-11.28%
Free Cash Flow Margin	-1.55%	-5.72%	-26.45%	-56.68%	-8.63%
EBITDA	-0.15	-2.94	-6.56	-10.88	-1.62
EBITDA Margin	-0.44%	-9.68%	-22.48%	-67.23%	-22.76%
D&A For EBITDA	0.49	0.36	0.77	0.36	0.03
EBIT	-0.64	-3.29	-7.34	-11.24	-1.65
EBIT Margin	-1.88%	-10.85%	-25.13%	-69.45%	-23.17%

Updated Aug 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.